Status:
ACTIVE_NOT_RECRUITING
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
Lead Sponsor:
Stanford University
Collaborating Sponsors:
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA)
Conditions:
Addiction, Opioid
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to expand access to medications for opioid use disorder (MOUD) in specialty addiction programs in Washington State. Sixty-four addiction treatment programs will participat...
Eligibility Criteria
Inclusion
- Addiction treatment programs in Washington State
- Residential (detoxification or rehabilitation) or outpatient (intensive outpatient or outpatient) levels of care
- Primary care clinics, including Federally Qualified Health Centers (FQHCs) and Community Health Centers (CHCs)
Exclusion
- Opioid treatment programs
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2026
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT05343793
Start Date
March 14 2022
End Date
June 30 2026
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington State Healthcare Authority
Olympia, Washington, United States, 98501